SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 257 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3UG3NS105703-03S1
A Lung-chip microphysiological system to model SARS-CoV-2 infection and test novel therapeutics
National Institutes of Health
Grant: 5RO1HL135163-04
National Institutes of Health
Grant: PO1HL108793-08
National Institutes of Health
Grant: 1R01EY032149
National Institutes of Health
Grant: T32HL134637
National Institutes of Health
Grant: NR-10361
National Institutes of Health
Grant: NR-52281
California Institute for Regenerative Medicine
Grant: TRAN1COVID19-11975
California Institute for Regenerative Medicine
Grant: EDUC2-08383
National Institutes of Health
Grant: 5R01EY032149-03
Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection
National Institutes of Health
Grant: 5T32HL134637-02
Multidisciplinary Pulmonary Research Training Program
National Institutes of Health
Grant: 1R01HL135163-01
Epithelial progenitor cells for lung repair and regeneration
National Institutes of Health
Grant: 5P01HL108793-10
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
FWCI
30.98
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients
Additional file 1 of Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients
Additional file 3 of Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients
Additional file 3 of Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients